Psychotropic Substances Act
PL 95-633 (S.2399), enacted 11/10/1978

92 STAT. 3768 
PUBLIC LAW 95-633—NOV. 10, 1978 
Public Law 95-633 
^ 
;. 
,:>_ . 
95th Congress 
An Act 
JNov. 10, 1978 
1
J
.
Q amend the Comprehensive Drug Abuse Prevention and Control Act of 1970 
[S. 2399] 
and other laws to meet obligations under the Convention on Psychotropic Sub-
stances relating to regulatory controls on the manufacture, distribution, 
importation, and exportation of psychotropic substances, and for other 
purposes. 
Be it enacted ty the Senate and House of Representatives of the 
Psychotropic 
United States of America in Congress assernbled, That this Act may 
Substances Act 
be cited as the "Psychotropic Substances Act of 1978". 
of 1978. 
"
^ 
^ 
21 use 801 note. ^riTLE I—ENABLING PEOVISIONS FOR THE CONVEN-
TION ON PSYCHOTEOPIC SUBSTANCES 
21 use 801a. 
SEC. 101. The Congress makes the following 
findings 
and 
declarations: 
(1) The Congress has long recognized the danger involved in 
the manufacture, distribution, and use of certain psychotropic 
substances for nonscientific and nonmedical purposes, and has 
provided strong and effective legislation to control illicit traffick-
ing and to regulate legitimate uses of psychotropic substances in 
this country. Abuse of psychotropic substances has become a 
phenomenon common to many countries, however, and is not con-
fined to national borders. It is, therefore, essential that the United 
States cooperate with other nations in establishing effective con-
trols over international traffic in such substances. 
(2) The United States has joined with other countries in execut-
ing an international treaty, entitled the Convention on Psycho-
tropic Substances and signed at Vienna, Austria, on February 21, 
1971, which is designed to establish suitable controls over the 
manufacture, distribution, transfer, and use of certain psycho-
tropic substances. The Convention is not self-executing, and the 
obligations of the United States thereunder may only be per-
formed pursuant to appropriate legislation. It is the intent of the 
Congress that the amendments made by this Act, together with 
existing law, will enable the United States to meet all of its obli-
gations under the Convention and that no further legislation will 
be necessary for that purpose. 
(3) In implementing the Convention on Psychotropic Sub-
stances, the Congress intends that, consistent with the obligations 
of the United States under the Convention, control of psycho-
tropic substances in the United States should be accomplished 
within the framework of the procedures and criteria for classifica-
tion of substances provided in the Comprehensive Drug Abuse 
21 use 801 note. 
Prevention and Control Act of 1970. This will insure that (A) 
the availability of psychotropic substances to manufacturers, dis-
tributors, dispensers, and researchers for useful and legitimate 
medical and scientific purposes will not be unduly restricted; (B) 
nothing in the Convention will interfere with bona fide research 
activities; and (C) nothing in the Convention will interfere with 
ethical medical practice in this country as determined by the Sec-
PUBLIC LAW 95-633—NOV. 10, 1978 
92 STAT. 3769 
Publication in 
Federal 
Register. 
retary of Health, Education, and Welfare on the basis of a con-
sensus of the views of the American medical and scientific 
community. 
SEC. 102. (a) Subsection (d) of section 201 of the Controlled Sub-
stances Act (21 U.S.C. 811(d)) is amended by inserting "(1)" after 
"(d)" and by adding the following new paragraphs at the end thereof: 
"(2) (A) Whenever the Secretary of State receives notification from 
the Secretary-General of the United JN^ations that information has 
been transmitted by or to the World Health Organization, pursuant 
to article 2 of the Convention on Psychotropic Substances, which 
may justify adding a drug or other substance to one of the schedules 
of the Convention, transferring a drug or substance from one sched-
ule to another, or deleting it from the schedules, the Secretary of 
State shall inmiediately transmit the notice to the Secretary of Health, 
Education, and Welfare who shall publish it in the Federal Register 
and provide opportunity to interested persons to submit to him com-
ments respecting the scientific and medical evaluations which he is 
to prepare respecting such drug or substance. The Secretary of 
Health, Education, and Welfare shall prepare for transmission 
through the Secretary of State to the World Health Organization 
such medical and scientific evaluations as may be appropriate regard-
ing the possible action that could be proposed by the World Health 
Organization respecting the drug or substance with respect to which 
a notice was transmitted under this subparagraph. 
"(B) Whenever the Secretary of State receives information that 
the Commission on Narcotic Drugs of the United Nations proposes 
to decide whether to add a drug or other substance to one of the 
schedules of the Convention, transfer a drug or substance from one 
schedule to another, or delete it from the schedules, the Secretary of 
State shall transmit timely notice to the Secretary of Health, Educa-
tion, and Welfare of such information who shall publish a summary 
of such information in the Federal Register and provide opportunity 
to interested persons to submit to him comments respecting the 
recommendation which he is to furnish, pursuant to this subpara-
graph, respecting such proposal. The Secretary of Health, Education, 
and Welfare shall evaluate the proposal and furnish a recommendation 
to the Secretary of State which shall be binding on the representative 
of the United States in discussions and negotiations relating to the 
proposal. 
"(3) When the United States receives notification of a scheduling 
decision pursuant to article 2 of the Convention on Psychotropic Sub-
stances that a drug or other substance has been added or transferred 
to a schedule specified in the notification or receives notification 
(referred to in this subsection as a 'schedule notice') that existing legal 
controls applicable under this title to a drug or substance and the con-
trols required by the Federal Food, Drug, and Cosmetic Act do not 21 USC 301 
meet the requirements of the schedule of the Convention in which such 
drug or substance has been placed, the Secretary of Health, Education, 
and Welfare, after consultation with the Attorney General, shall first 
determine whether existing legal controls under this title applicable to 
the drug or substance and the controls required by the Federal Food, 
Drug, and Cosmetic Act, meet the requirements of the schedule 
specified in the notification or schedule notice and shall take the 
following action: 
"(A) If such i-equirements are met by such existing controls 
but the Secretary of Health, Education, and Welfare nonetheless 
Publication in 
Federal 
Register. 
39-194 O-80-pt. 3 
72 : QL3 
92 STAT. 3770 
PUBLIC LAW 95-633—NOV. 10, 1978 
believes that more stringent controls should be applied to the 
drug or substance, the Secretary shall recommend to the Attorney 
General that he initiate proceedings for scheduling the drug or 
substance, pursuant to subsections (a) and (b) of this section, 
to apply to such controls. 
" (B) If such requirements are not met by such existing controls 
and the Secretary of Health, Education, and Welfare concurs in 
the scheduling decision or schedule notice transmitted by the 
notification, the Secretary shall recommend to the Attorney Gen-
eral that he initiate proceedings for scheduling the drug or sub-
stance under the appropriate schedule pursuant to subsections (a) 
and (b) of this section. 
"(C) If such requirements are not met by such existing controls 
and the Secretary of Health, Education, and Welfare does not 
•f- ' 
concur in the scheduling decision or schedule notice transmitted by 
the notification, the Secretary shall— 
"(i) if he deems that additional controls are necessary to 
protect the public health and safety, recommend to the Attor-
ney General that he initiate proceedings for scheduling the 
drug or substance pursuant to subsections (a) and (b) of this 
section, to apply such additional controls; 
"(ii) request the Secretary of State to transmit a notice of 
qualified acceptance, within the period specified in the Con-
vention, pursuant to paragraph 7 of article 2 of the Conven-
tion, to the Secretary-General of the United Nations; 
"(iii) request the Secretary of State to transmit a notice 
of qualified acceptance as prescribed in clause (ii) and 
request the Secretary of State to ask for a review by the 
Economic and Social Council of the United Nations, in 
accordance with paragraph 8 of article 2 of the Convention, 
of the scheduling decision; or 
' '•.- 
"(iv) in the case of a schedule notice, request the Secretary 
of State to take appropriate action under the Convention to 
initiate proceedings to remove the drug or substance from 
the schedules under the Convention or to transfer the drug 
or substance to a schedule under the Convention different 
from the one specified in the schedule notice. 
"(4) (A) If the Attorney General determines, after consultation 
with the Secretary of Health, Education, and Welfare, that pro-
ceedings initiated under recommendations made under paragraph 
(B) or (C)(i) of paragraph (3) will not be completed within the 
time period required by paragraph 7 of article 2 of the Convention, 
the Attorney General, after consultation with the Secretary and 
after providing interested persons opportunity to submit comments 
respecting the requirements of the temporary order to be issued 
under this sentence, shall issue a temporary order controlling the 
drug or substance under schedule I V or V, whichever is most appro-
priate to carry out the minimum United States obligations under 
paragraph 7 of article 2 of the Convention. As a part of such order, 
the Attorney General shall, after consultation with the Secretary, 
except such drug or substance from the application of any provision 
of part C of this title which he finds is not required to carry out the 
United States obligations under paragraph 7 of article 2 of the Con-
Notice, 
vention. In the case of proceedings initiated under subparagraph (B) 
of paragraph (3), the Attorney General, concurrently with the issu-
PUBLIC LAW 95-633—NOV. 10, 1978 
92 STAT. 3771 
ance of such order, shall request the Secretary of State to transmit 
a notice of qualified acceptance to the Secretary-General of the United 
Nations pursuant to paragraph 7 of article 2 of the Convention. A 
temporary order issued under this subparagraph controlling a drug 
or other substance subject to proceedings initiated under subsections 
(a) and (b) of this section shall expire upon the effective date of 
the application to the drug or substance of the controls resulting from 
such proceedings. 
* 
"(B) After a notice of qualified acceptance of a scheduling decision 
with respect to a drug or other substance is transmitted to the Secre-
tary-General of the United Nations in accordance with clause (ii) 
or (iii) of paragraph (3) (C) or after a request has been made under 
clause (iv) of such paragraph with respect to a drug or substance 
described in a schedule notice, the xittorney General, after consul-
tation with the Secretary of Health, Education, and Welfare and 
after providing interested persons opportunity to submit comments 
a )
>
* j L 
respecting the requirements of the order to be issued under this sen-
tence, shall issue an order controlling the drug or substance under 
schedule IV or V, whichever is most appropriate to carry out the 
minimum United States obligations under paragraph 7 of article 
2 of the Convention in the case of a drug or substance for which a 
notice of qualified acceptance was transmitted or whichever the 
Attorney General determines is appropriate in the case of a drug 
or substance described in a schedule notice. As a part of such order, 
the Attorney General shall, after consultation with the Secretary, 
except such drug or substance from the application of any provision 
? 
of part C of this title which he finds is not required to carry out the 
United States obligations under paragraph 7 of article 2 of the Con- 
•..'•;' 
veutiou. If, as a result of a review under paragraph 8 of article 2 of 
the Convention of the scheduling decision with respect to which a 
' 
notice of qualified acceptance was transmitted in accordance with 
clause (ii) or (iii) of paragraph (3) (C) — 
" (i) the decision is reversed, and 
"(ii) the drug or substance subject to such decision is not 
required to be controlled under schedule IV or V to carry out 
the minimum United States obligations under paragraph 7 of 
article 2 of the Convention, 
the order issued under this subparagraph with respect to such drug 
or substance shall expire upon receipt by the United States of the 
review decision. If, as a result of action taken pursuant to action 
initiated under a request transmitted under clause (iv) of paragraph 
(3) (C), the drug or substance with respect to which such action was 
taken is not required to be controlled under schedule IV or V, the 
order issued under this paragraph with respect to such drug or sub-
stance shall expire upon receipt by the United States of a notice of 
the action taken with respect to such drug or substance under the 
Convention. 
"(C) An order issued under subparagraph (A) or (B) may be 
issued Avithout regard to the findings required by subsection (a) of 
this section or by section 202(b) and without regard to the procedures 
prescribed by subsection (a) or (b) of this section. 
"(5) Nothing in the amendments made by the Psychotropic Sub-
stances Act of 1978 or the regulations or orders promulgated there- ^nte, p. 3768. 
under shall be construed to preclude requests by the Secretary of 
Health, Education, and Welfare or the Attorney General through the 
92 STAT. 3772 
PUBLIC LAW 95-633—NOV. 10, 1978 
"Convention on 
Psychotropic 
Substances." 
21 u s e 812 note. 
Secretary of State, pursuant to article 2 or other applicable provisions 
of the Convention, for review of scheduling decisions under such 
Convention, based on new or additional information.". 
(b) Section 102 of the Controlled Substances Act (21 U.S.C. 802) 
is amended by adding at the end the following: 
"(29) The term 'Convention on Psychotropic Substances' means the 
Convention on Psychotropic Substances signed at Vienna, Austria, on 
February 21, 1971; and the term 'Single Convention on Narcotic 
Drugs' means the Single Convention on Narcotic Drugs signed at New 
York, New York, on March 30,1961.". 
(c) For the purpose of carrying out the minimum United States 
obligations under paragraph 7 of article 2 of the Convention on Psy-
chotropic Substances, signed at Vienna, Austria, on February 21, 
1971, with respect to pipradrol and S P A (also known as 
(-)-l-
dimethylamino-l,2-diphenylethane), the Attorney General shall by 
21 use 811,812. order, made without regard to sections 201 and 202 of the Controlled 
Substances Act, place such drugs in schedule IV of such Act. 
SEC. 103. Subsection (d) of section 202 of the Controlled Sub-
stances Act (21 U.S.C. 812(d)) is amended by striking out "and" 
before " ( 2 ) " and by adding the following before the period at the 
end thereof: ", and (3) such exception does not conflict with United 
States obligations under the Convention on Psychotropic Substances". 
SEC. 104. Section 307 of the Controlled Substances Act (21 U.S.C. 
827) is amended by redesignating subsection (e) as subsection (f) 
and by inserting after subsection (d) the following new subsection: 
"(e) In addition to the reporting and recordkeeping requirements 
under any other provision of this title, each manufacturer registered 
under section 303 shall, with respect to narcotic and nonnarcotic con-
trolled substances manufactured by it, make such reports to the 
Attorney General, and maintain such records, as the Attorney General 
may require to enable the United States to meet its obligations under 
articles 19 and 20 of the Single Convention on Narcotic Drugs and 
article 16 of the Convention on Psychotropic Substances. The Attorney 
General shall administer the requirements of this subsection in such 
a manner as to avoid the unnecessary imposition of duplicative 
requirements under this title on manufacturers subject to the require-
ments of this subsection.". 
SEC. 105. Section 1002(b) of the Controlled Substances Import and 
Export Act (21 U.S.C. 952(b)) is amended by inserting immediately 
before the period at the end of paragraph 
(2) the 
following: 
", except that if a nonnarcotic controlled suljstance in schedule I I I , IV, 
or V is also listed in schedule I or I I of the Convention on Psycho-
tropic Substances it shall be imported pursuant to such import permit 
requirements, prescribed by regulation of the Attorney General, as 
are required by the Convention". 
SEC. 106. Subsection (e) of section 1003 of the Controlled Sub-
stances Import and Export Act (21 U.S.C. 953(e)) is amended— 
(1) by striking out ", and" at the end of paragraph (2) and 
inserting in lieu thereof a semicolon; 
(2) by striking out the period at the end of paragraph (3) and 
inserting in lieu thereof "; and"; and 
(3) by adding after paragraph (3) the following new para-
graph : 
"(4) in any case when a nonnarcotic controlled substance in 
schedule I I I , IV, or V is also listed in schedule I or I I of the 
21 use 823. 
PUBLIC LAW 95-633—NOV. 10, 1978 
92 STAT. 3773 
Convention on Psychotropic Substances, it is exported pursuant 
to such export permit requirements, prescribed by regulation of 
the Attorney General, as are required by the Convention, instead 
of the invoice required by paragraphs (2) and (3) of this sub-
SEC. 107 (a) Part D of the Controlled Substances Act (21 U.S.C. 
841 et seq.) is amended by adding at the end thereof the following 
new section: 
"APPLICATION OF TREATIES AND OTHER INTERNATIONAL AGREEMENTS 
"SEC. 412. Nothing in the Single Convention on Narcotic Drugs, the 21 USC 852. 
Convention on Psychotropic Substances, or other treaties or inter-
national agreements shall be construed to limit the provision of treat-
ment, education, or rehabilitation as alternatives to conviction or 
criminal penalty for offenses involving any drug or other substance 
subject to control under any such treaty or agreement.". 
(b) The table of contents of the Comprehensive Drug Abuse Pre-
vention and Control Act of 1970 is amended by inserting— 
21 USC 801 note. 
"Sec. 412. Application of treaties and other international agreements." 
immediately after 
^ 
"Sec. 411. Proceedings to establish previous convictions.". 
SEC. 108. (a) Section 602 of the Controlled Substances Act (21 
• *
; • 
* • : 
U.S.C. 872) is amended by redesignating subsection (d) as subsection 
(e), and by adding after subsection (c) the following new subsection: 
"(d) Nothing in the Single Convention on Narcotic Drugs, the 
Convention on Psychotropic Substances, or other treaties or interna-
tional agreements shall be construed to limit, modify, or prevent the 
protection of the confidentiality of patient records or of the names 
and other identifying characteristics of research subjects as provided 
by any Federal, State, or local law or regulation.". 
(b) Section 303 of the Public Health Service Act (42 U.S.C. 242a) 
is amended by redesignating subsection (b) as subsection (c), and 
by adding after subsection (a) the following new subsection: 
"(b) Nothing in the Single Convention on Narcotic Drugs, the 
Convention on Psychotropic Substances, or other treaties or interna-
tional agreements shall be construed to limit, modify, or prevent the 
protection of the confidentiality of patient records or of the names 
and other identifying characteristics of research subjects as provided 
by any Federal, State, or local law or regulation.". 
SEC. 109. Subsection (f) of section 303 of the Controlled Substances 
Act (21 U.S.C. 823(f)) is amended by adding at the end the follow-
ing sentence: "Article 7 of the Convention on Psychotropic Substances 
shall not be construed to prohibit, or impose additional restrictions 
upon, research involving drugs or other substances scheduled under 
the Convention which is conducted in conformity with this subsection 
and other applicable provisions of this title.". 
SEC. 110. Subsection (c) of section 307 of the Controlled Sub-
stances Act (21 U.S.C. 827(c)) is amended by adding the following 
after and below paragraph (3) : "Nothing in the Convention on 
Psychotropic Substances shall be construed as superseding or other-
wise affecting the provisions of paragraph ( 1 ) ( B ) , (2), or (3) of 
this subsection.". 
SEC. 111. Subsection (n) of section 502 of the Federal Food, Drug, 
and Cosmetic Act (21 U.S.C. 352(n)) is amended by adding the fol-
92 STAT. 3774 
PUBLIC LAW 95-633—NOV. 10, 1978 
lowing new sentence at the end thereof: "Nothing in the Convention 
on Psychotropic Substances, signed at Vienna, Austria, on Febru-
ary 21,1971, shall be construed to prevent drug price communications 
to consumers.". 
Effective date. 
SEC. 112. This title and the amendments made by this title shall 
21 use 801a 
take effect on the date the Convention on Psychotropic Substances, 
^°^^' 
signed at Vienna, Austria on February 21, 1971, enters into force in 
respect to the United States. 
• • • " 
•» 
T I T L E I I — P C P C R I M I N A L P E N A L T I E S A N D P I P E R I D I N E 
R E P O R T I N G 
SEC. 201. Section 401 of the Controlled Substances Act (21 U.S.C. 
841) is amended— 
(1) by inserting ", except as provided in paragraphs (4) and 
(5) of this subsection," after "such person shall" in the first 
sentence of subsection (b) (1) (B) ; 
, ...^ , 
(2) by adding after paragraph (4) of subsection (b) the fol-
•" 
' 
lowing new paragraph: 
"(5) Notwithstanding paragraph (1) (B) of this subsection, any 
person who violates subsection (a) of this section by manufacturing, 
distributing, dispensing, or possessing with intent to manufacture, 
distribute, or dispense, except as authorized by this title, phencyclidine 
Post, f. 3775. 
(as defined in section 310(c)(2)) shall be sentenced to a term of 
imprisonment of not more than 10 years, a fine of not more than 
$25,000, or both. If any person commits such a violation after one 
or more prior convictions of him for an offense punishable under j)ara-
graph (1) of this paragraph, or for a felony under any other provision 
of this title or title I I I or other law of the United States relating to 
narcotic drugs, marihuana, or depressant or stimulant substances, 
have become final, such person shall be sentenced to a term of imprison-
ment of not more than 20 years, a fine of not more than $50,000, or 
both. Any sentence imposing a term of imprisonment under this 
paragraph shall, in the absence of such a prior conviction, impose 
a special parole term of at least 2 years in addition to such term of 
imprisonment and shall, if there was such a prior conviction, impose 
a special parole term of at least 4 years in addition to such term of 
imprisonment."; and 
(3) by adding after subsection (c) the following new sub-
section : 
"(d) Any person who knowingly or intentionally— 
"(1) possesses any piperidine with intent to manufacture 
phencyclidine except as authorized by this title, or 
"(2) possesses any piperidine knowing, or having reasonable 
cause to believe, that the piperidine will be used to manufacture 
phencyclidine except as authorized by this title, 
shall be sentenced to a term of imprisonment of not more than 5 
years, a fine of not more than $15,000, or both.". 
SEC. 202. (a) Part C of the Controlled Substances Act is amended 
(1) by inserting " ; PIPERIDINE REPORTING" at the end of its heading, 
and (2) by adding after section 309 (21 U.S.C. 829) the following 
new section: 
PUBLIC LAW 95-633—NOV. 10, 1978 
92 STAT. 3775 
. ;t:>i-. 
5 
"PIPERIDINE REPORTING 
:-
"SEC. 310. (a)(1) Except as provided under paragraph (3), any 21 USC 830. 
person who distributes, sells, or imports any piperidine shall report 
to the Attorney General such information, in such form and manner, 
and within such time period or periods (of not less than seven days), 
concerning the distribution, sale, or importation as the Attorney 
General may require by regulation, and the person shall preserve a 
copy of each such report for 2 years. The Attorney General may 
include in the information required to be reported the following: 
"(A) The quantity, form, and manner in which, and date 
on which, the piperidine was distributed, sold, or imj)orted. 
"(B) (i) In the case of the distribution or sale of piperidine to 
an individual, the name, address, and age of the individual and 
the type of identification presented to confirm the identity of 
the individual. 
"(ii) In the case of the distribution or sale of piperidine to 
an entity other than an individual, the name and address of the 
; '•• ' 
entity and the name, address, and title of the individual order-
ing or receiving the piperidine and the type of identification 
presented to confirm the identity of the individual and of the 
entity. 
"(2) Except as provided under paragraph (3), no person may 
distribute or sell piperidine unless the recipient or purchaser presents 
to the distributor or seller identification of such type, to confirm the 
identity of the recipient or purchaser (and any entity which the recip-
ient or purchaser represents), as the Attorney General establishes 
by regulation. 
"(3) Under such conditions and to such extent as the Attorney 
General establishes, paragraphs (1) and (2) shall not apply to— 
"(A) 
the distribution of piperidine between agents or 
employees within a single facility (as defined by the Attorney 
General), if such agents or employees are acting in the lawful 
and usual course of their business or emplojonent; 
"(B) the delivery of piperidine to or by a common or contract 
carrier for carriage in the lawful and usual course of its business, 
i 
or to or by a warehouseman for storage in the lawful and usual 
course of its business; but where such carriage or storage is in 
connection with the distribution, sale, or importation of the 
piperidine to a third person, this subparagraph shall not relieve 
the distributor, seller, or importer from compliance with para-
graph (1) or (2); or 
"(C) any distribution, sale, or importation of piperidine with 
respect to which the Attorney General determines that the report 
required by paragraph (1) or the presentation of identification 
required by paragraph (2) is not necessary for the enforcement 
of this title. 
"(b) Any information which is reported to or otherwise obtained 
by the Department of Justice under this section and which is exempt 
from disclosure pursuant to subsection (a) of section 552 of title 5, 
United States Code, by reason of subsection (b) (4) thereof shall be 
considered confidential and shall not be disclosed, except that such 
information may be disclosed to officers or employees of the United 
States concerned with carrying out this title or title III or when 
relevant in any proceeding for the enforcement of this title or title III. 
ik 
92 STAT. 3776 
PUBLIC LAW 95-633—NOV. 10, 1978 
Definitions. 
21 use 841, 
842. 
21 use 951. 
Ante, p. 3775. 
"(c) For purposes of this section, section 401(d), and section 
402(a)(9): 
"(1) The term 'import' has the meaning given such term in 
section 1001(a)(1). 
"(2) The term 'phencyclidine' means l-(l-phenylcyclohexyl) 
piperidine, its salts, or any immediate precursor, homolog, analog, 
or derivative (or salt thereof) of l-(l-phenylcyclohexyl) piper-
idine that is included in schedule I or II of part B of this title. 
"(3) The term 'piperidine' includes its salts and acyl 
derivatives.". 
(b) (1) Section 402(a) of such Act (21 U.S.C. 842(a)) is amended— 
(A) by striking out "or" at the end of paragraph (7); 
(B) by striking out the period at the end of paragraph (8) and 
inserting in lieu thereof "; or"; and 
(C) by adding after paragraph (8) the following new 
paragraph: 
"(9) to distribute or sell piperidine in violation of regulations 
established under section 310(a)(2), respecting presentation of 
identification.". 
(2) Section 402(c)(2) of such Act (21 U.S.C. 842(c)(2)) is 
amended by adding after subparagraph (B) the following new 
subparagraph: 
"(C) Subparagraphs (A) and (B) shall not apply to a violation of 
subsection (a)(5) with respect to a refusal or failure to make a report 
required under section 310(a) (relating to piperidine reporting).". 
(3) Section 403(a)(4) of such Act (21 U.S.C. 843(a)(4)) " 
amended— 
(A) by inserting "(A)" after "(4)", and 
(B) by inserting before "; or" the following: ", or (B) 
present false or fraudulent identification where the person 
receiving or purchasing piperidine and the person is required to 
present identification under section 310 (a)". 
(c) The table of contents of the Comprehensive Drug Abuse 
Prevention and Control Act of 1970 is amended— 
(1) by inserting "; PIPERIDINE REPORTING" at the end of the 
item relating to part C, and 
(2) by adding immediately after the item relating to section 
309 the following new item: 
"Sec. 310. Piperidine reporting.". 
21 use830 note. 
SEC. 203. (a)(1) Except as provided under paragraph (2), the 
amendments made by this title shall take effect on the date of the 
enactment of this Act. 
(2) Any person required to submit a report under section 310 
(a) (1) of the Controlled Substances Act respecting a distribution, 
sale, or importation of piperidine during the 90 days after the date 
of the enactment of this Act may submit such report any time up to 
97 days after such date of enactment. 
(3) Until otherwise provided by the Attorney General by regula-
tion, the information required to be reported by a person under 
section 310(a) (1) of the Controlled Substances Act (as added by 
section 202(a) (2) of this title) with respect to the person's distribu-
tion, sale, or importation of piperidine shall— 
(A) be the information described in subparagraphs (A) and 
(B) of such section, and 
(B) except as provided in paragraph (2) of this subsection, 
be reported not later than seven days after the date of such 
distribution, sale, or importation. 
IS 
to 
is 
21 use 801 note. 
21 use 829. 
PUBLIC LAW 95-633—NOV. 10, 1978 
92 STAT. 3777 
(b) The Attorney General shall— 
(1) first publish proposed interim regulations to carry out 
the requirements of section 310(a) of the Controlled Substances 
Act (as added by section 202(a) (2) of this title) not later than 
30 days after the date of the enactment of this Act, and 
' 
(2) first promulgate final interim regulations to carry out such 
requirements not later than 75 days after the date of the enact-
ment of this Act, such final interim regulations to be effective 
with respect to distributions, sales, and importations of piperi-
dine on and after the ninety-first day after the date of the 
enactment of this Act. 
(c) The Attorney General, after consultation with the Secretary 
of Health, Education, and Welfare, shall analyze and evaluate the 
impact and effectiveness of the amendments made by this title, 
including the impact on the illicit manufacture and use of phency-
clidine and the impact of the requirements imposed by such amend-
ments on legitimate distributions and uses of piperidine. Not later Report to 
than March 1, 1980, the Attorney General shall report to the President and 
President and the Congress on such analysis and evaluation and shall Congress, 
include in such report such recommendations as the Attorney General 
deems appropriate. 
(d) On January 1, 1981, section 310, subsection (d) of section 401, Repeals. 
paragrajDh (9) of section 402(a), subparagraph (C) of section 402(c) 
(2), and clause (B) of section 403(a)(4) of the Controlled Sub-
stances Act (as added by this title) are repealed. 
-^nte, p. 3775, 
3776. 
TITLE III—FOEFEITITRE, OF PROCEEDS OF 
ILLEGAL DRUG TRANSACTIONS 
SEC. 301. (a) Section 511 of the Comprehensive Drug Abuse Pre-
vention and Control Act (21 U.S.C. 881) is amended— 
(1) by adding at the end of subsection (a) the following new 
paragraph: 
"(6) All moneys, negotiable instruments, securities, or other 
things of value furnished or intended to be furnished by any 
person in exchange for a controlled substance in violation of this 
title, all proceeds traceable to such an exchange, and all moneys, 
negotiable instruments, and securities used or intended to be 
used to facilitate any violation of this title, except that no prop-
erty shall be forfeited under this paragraph, to the extent of the 
interest of an owner, by reason of any act or omission established 
by that owner to have been committed or omitted without the 
knowledge or consent of that owner." ; 
(2) in subsection (e) (2) by striking out ", but the proceeds" 
and all that follows through "court costs"; and 
(3) by adding at the end of subsection (e) the following new 
sentence: 
i:^r^ 
92 STAT. 3778 
PUBLIC LAW 95-633—NOV. 10, 1978 
"The proceeds from any sale under paragraph (2) and any moneys 
forfeited under this title shall be used to pay all proper expenses of 
the proceedings for forfeiture and sale including expenses of seizure, 
maintenance of custody, advertising, and court costs. The Attorney 
General shall forward to the Treasurer of the United States for 
deposit in the general fund of the United States Treasury any 
amounts of such moneys and proceeds remaining after payment of 
such expenses.". 
(b) The second sentence of section 1015 of such Act (21 U.S.C. 
965) is amended by inserting "or 511" after "510" each place it 
appears. 
Approved November 10, 1978. 
« 
t' ".' i 
'•i^-ni UW/! 
LEGISLATIVE HISTORY: 
HOUSE REPORT No. 95-1193 accompanying H.R. 12008 (Comm. on Interstate and 
Foreign Commerce). 
SENATE REPORT No. 95-959 (Comm. on the Judiciary). 
CONGRESSIONAL RECORD, Vol. 124 (1978): 
July 27, considered and passed Senate. 
Sept. 18, considered and passed House, amended, in lieu of H.R. 12008. 
Oct. 7, Senate concurred in House amendment with amendments. 
Oct. 13, House concurred in Senate amendments. 
WEEKLY COMPILATION OF PRESIDENTIAL DOCUMENTS, Vol. 14, No. 45: 
Nov. 10, Presidential statement.